MainStreet Investment Advisors LLC Sells 6,004 Shares of UnitedHealth Group Incorporated $UNH

MainStreet Investment Advisors LLC decreased its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 62.9% in the third quarter, HoldingsChannel reports. The firm owned 3,545 shares of the healthcare conglomerate’s stock after selling 6,004 shares during the quarter. MainStreet Investment Advisors LLC’s holdings in UnitedHealth Group were worth $1,224,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of the company. Trajan Wealth LLC boosted its position in shares of UnitedHealth Group by 33.9% during the 3rd quarter. Trajan Wealth LLC now owns 85,293 shares of the healthcare conglomerate’s stock valued at $29,452,000 after acquiring an additional 21,609 shares during the last quarter. Sound View Wealth Advisors Group LLC grew its stake in shares of UnitedHealth Group by 41.6% in the 3rd quarter. Sound View Wealth Advisors Group LLC now owns 5,034 shares of the healthcare conglomerate’s stock worth $1,738,000 after buying an additional 1,479 shares in the last quarter. Marks Group Wealth Management Inc raised its position in shares of UnitedHealth Group by 143.1% during the 3rd quarter. Marks Group Wealth Management Inc now owns 47,802 shares of the healthcare conglomerate’s stock valued at $16,506,000 after buying an additional 28,142 shares in the last quarter. Intelligence Driven Advisers LLC grew its position in UnitedHealth Group by 8.4% in the third quarter. Intelligence Driven Advisers LLC now owns 706 shares of the healthcare conglomerate’s stock worth $244,000 after acquiring an additional 55 shares in the last quarter. Finally, X Square Capital LLC purchased a new stake in UnitedHealth Group during the third quarter valued at approximately $1,036,000. 87.86% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of analyst reports. Evercore upgraded UnitedHealth Group to a “strong-buy” rating in a research report on Tuesday, January 6th. Truist Financial cut their price target on shares of UnitedHealth Group from $410.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, February 2nd. Leerink Partners dropped their target price on UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating for the company in a research report on Wednesday, January 28th. Weiss Ratings restated a “hold (c-)” rating on shares of UnitedHealth Group in a report on Wednesday, January 21st. Finally, Jefferies Financial Group cut their price target on shares of UnitedHealth Group from $418.00 to $340.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. One investment analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $372.13.

Check Out Our Latest Research Report on UNH

UnitedHealth Group Price Performance

NYSE UNH opened at $290.11 on Monday. The firm’s 50 day moving average price is $316.85 and its 200-day moving average price is $325.30. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.82 and a current ratio of 0.79. The company has a market cap of $262.79 billion, a PE ratio of 21.99, a P/E/G ratio of 1.33 and a beta of 0.41. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $606.36.

UnitedHealth Group (NYSE:UNHGet Free Report) last issued its quarterly earnings data on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, beating analysts’ consensus estimates of $2.09 by $0.02. The company had revenue of $113.22 billion for the quarter, compared to the consensus estimate of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The firm’s revenue for the quarter was up 12.3% compared to the same quarter last year. During the same quarter last year, the company earned $6.81 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.